In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against Aspergillus and Candida

SCH 56592 (posaconazole), a new triazole antifungal agent, was tested in vitro, and its activity was compared to that of itraconazole against 39 Aspergillus strains and to that of fluconazole against 275 Candida and 9 Cryptococcus strains. The SCH 56592 MICs for Aspergillus ranged from ≤0.002 to 0.5...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cacciapuoti, Anthony, Loebenberg, David, Corcoran, Erik, Menzel, Fred, Moss, Eugene L., Norris, Christine, Michalski, Monika, Raynor, Kimberly, Halpern, Judith, Mendrick, Cara, Arnold, Brian, Antonacci, Barry, Parmegiani, Raulo, Yarosh-Tomaine, Taisa, Miller, George H., Hare, Roberta S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2000
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC90007/
https://ncbi.nlm.nih.gov/pubmed/10898669
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados